TOP NEWS

Equillium Raises $65M In IPO

La Jolla-based biotech firm Equillium raised $65M in its IPO last week, selling 4,700,000 shares of its common stock at $14.00 per share. The company is now listed on the Nasdaq Global Market as EQ. The IPO was underwritten by Jefferies, Leerink Partners, and Stifel. Equilium's main backer is Biocom SA. Equillium develops treatments for autoimmune an

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.